Stock Analiz

AdaptHealth Corp. (AHCO) stock forecast and price target

Price $7.66 · data as of November 13, 2026

12-month price target

Average target$8.86
Upside / downside+15.6%
Analysts7
ConsensusStrong buy
Low $8.00Average $8.86High $10.00

Gold marker: average target · white marker: today’s price ($7.66)

Analyst ratings

Strong buy 1Buy 6Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.98−281.2%$2.9B
Next fiscal year
ends December 31, 2027
$-0.16+83.4%$3.0B
Next quarter
ends December 31, 2026
$-0.04−113.6%$720M
Quarter after
ends March 31, 2027
$-0.09−79.6%$721M

Consensus of the analysts covering AdaptHealth, updated daily.

Our model vs. Wall Street

Analysts see 15.6% upside over 12 months. Our discounted cash flow model with moderate assumptions puts AdaptHealth’s intrinsic value about 34% below today’s market value, and it scores 1.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the AdaptHealth stock price target?

The average 12-month target from 7 analysts is $8.86, 15.6% above the current price of $7.66 Targets range from $8.00 to $10.00.

Is AdaptHealth a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 6 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is AdaptHealth expected to earn?

Analysts expect EPS of $-0.98 for the fiscal year ending December 31, 2026 and $-0.16 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.